Related Experiment Videos

[Marfan syndrome and heart valve diseases]

M Pasic1, M Bauer, R Hetzer

  • 1Deutsches Herzzentrum Berlin Klinik für Herz-, Thorax- und Gefässchirurgie Augustenburger Platz 1 13353 Berlin, Germany. pasic@dhzb.de

Zeitschrift Fur Kardiologie
|February 6, 2002
PubMed

Insights

Surgical interventions for Marfan syndrome (MFS) cardiovascular complications, including aortic valve preservation, are detailed. Long-term outcomes of preserving the native aortic valve in MFS patients require further investigation.

Area of Science:

  • Cardiovascular Surgery
  • Genetics
  • Connective Tissue Diseases

Background:

  • Marfan syndrome is a hereditary connective tissue disorder with high cardiovascular mortality.
  • Aortic root dilatation and dissection are common, life-threatening complications.

Purpose of the Study:

  • To report surgical treatment outcomes for 243 Marfan syndrome patients with cardiovascular complications.
  • To evaluate classical surgical techniques (Bentall-DeBono, Cabrol) and aortic valve-sparing procedures.

Main Methods:

  • Review of surgical cases involving 243 Marfan syndrome patients.
  • Application of Bentall-DeBono and Cabrol procedures for annulo-aortic ectasia.
  • Aortic valve preservation with concomitant mitral valve surgery.

Main Results:

  • Surgical treatment was performed on 243 patients with Marfan syndrome and cardiovascular issues.
  • Classical methods and aortic valve-sparing techniques were employed.
  • Mitral valve surgery was performed based on established indications.

Conclusions:

  • Surgical management of cardiovascular complications in Marfan syndrome is feasible.
  • Aortic valve preservation and mitral valve reconstruction are possible in select Marfan syndrome patients.
  • Long-term results of aortic valve-sparing procedures in Marfan syndrome remain to be determined.

Related Concept Videos